We used a data mining approach and identified the p21 protein-activated kinase 1 (PAK1), an oncogene and drugable protein kinase, to be among the most promising targets for GEJ adenocarcinoma. The gene discussed is WEE1; the disease is gastroesophageal junction adenocarcinoma.